COVİD-19 PANDEMİ ÖNCESİ VE PANDEMİ DÖNEMİNDE ÇOCUK HASTALARDA İNFLUENZA TANISI VE KLİNİK BULGULARININ DEĞERLENDİRİLMESİ

Year 2021, , 613 - 619, 30.12.2021

Ömer Okuyan , Suna Kızılyıldırım , Adnan Barutçu , Özlem Erkan

https://doi.org/10.17343/sdutfd.971092

Abstract

Amaç
İnfluenza önemli bir halk sağlığı sorunudur. Özellikle
çocuklarda, kronik hastalıkları bulunan ve bağışıklığı
baskılanmış kişilerde ciddi akut solunum yolu enfeksiyonlarına
sebep olurlar. Çalışmada çocuk hastalarda
Covid-19 pandemi öncesi ve pandemi döneminde İnfluenza
vakalarının sıklığı ve hastaların klinik bulgularının
değerlendirilmesi amaçlandı.
Gereç ve Yöntem
Çalışmaya, 01.03.2019-11.03.2021 tarihleri arasında
Atlas Üniversitesi Tıp Fakültesi Çocuk Acil ve Genel
Çocuk Poliklinikleri'ne başvuran ve İnflueanza tanısı
alan 0-18 yaş arasındaki hastalar dahil edildi. Hastaların
klinik özellikleri, yatış oranı, komplikasyonlar,
pandemi öncesi ve pandemi dönemindeki sıklığı aylara
göre dağılımı incelendi.
Bulgular
Olguların %55.6’sı (n=594) erkek, %44.4'ü (n=475)
kız idi. Çalışma toplamda 1069 hasta ile tamamlandı.
Çalışma sonucunda en fazla görülen semptomlar
sırasıyla ateş (%96.5), öksürük (%51), halsizlik (%42)
ve burun akıntısı (%30.8) idi. Hastaların %93.2’si Covid-
19 pandemi öncesi döneme aitti. İnfluenza virusunun
Ocak ayında pik yaptığı ve Covid-19 pandemi
sürecinde İnfluenza B tipinin daha sık görüldüğü saptandı.
Sonuç
Sonuç olarak, ilk Covid-19 vakasının görüldüğü tarihten
itibaren alınan tedbirlerle İnfluenza’nın azaldığı
görüldü.

Keywords

İnfuenza A, İnfluenza B, Semptomlar, Covid-19, Pandemi

Supporting Institution

-

Project Number

-

Thanks

ATLAS ÜNİVERSİTESİ TIP FAKÜLTESİ MEDİCİNE HOSPİTAL'A KATKILARINDAN DOLAYI TEŞEKKÜR EDERİZ

DIAGNOSIS OF INFLUENZA AND EVALUATION OF CLINICAL FINDINGS IN CHILD PATIENTS BEFORE THE COVID-19 PANDEMIC AND DURING THE PANDEMIC PERIOD

Abstract

Objective
Influenza is an important public health problem.
They cause severe acute respiratory tract infections,
especially in children, people with chronic diseases and
immunosuppressed individuals. The aim of the study
was to evaluate the frequency of Influenza cases and
the clinical findings of the patients before the Covid-19
pandemic and during the pandemic period.
Material and Methods
Patients aged 0-18 years, who applied to Atlas
University Medical Faculty Pediatric Emergency and
General Pediatric Polyclinics between 01.03.2019
and 11.03.2021 and were diagnosed with influenza,
were included in the study. The clinical features of
the patients, the rate of hospitalization, complications,
the frequency before and during the pandemic,
distribution by months were examined.
Results
55.6% (n=594) of the cases were male and 44.4%
(n=475) were female. The study was completed with
a total of 1069 patients. As a result of the study, the
most common symptoms were fever (96.5%), cough
(51%), fatigue (42%) and nasal discharge (30.8%).
93.2% of the patients belonged to the pre-Covid-19
pandemic period. It was determined that influenza
virus peaked in January and influenza B type was
seen more frequently during the Covid-19 pandemic
period.
Conclusion
As a result, it was seen that Influenza decreased with
the measures taken since the first Covid-19 case was
seen.

Keywords

Influenza A, Influenza B, Symptoms, Covid-19, Pandemic

Project Number

-

References

• 1. Antonova EN, Rycroft CE, Ambrose CS, Heikkinen T, Principi N. Burden of paediatric Influenza in Western Europe: a systematic review. BMC Public Health 2012;12:968.
• 2. Lampejo T. Influenza and antiviral resistance: an overview. Eur J Clin Microbiol Infect Dis 2020;13:1-8.
• 3. Alexander-Miller MA. Challenges for the Newborn Following Influenza Virus Infection and Prospects for an Effective Vaccine. Front Immunol 2020;11:568651.
• 4. Jung HE, He Lee HK. Host Protective Immune Responses against Influenza A Virus Infection. Viruses 2020; 12(5):504.
• 5. Shafik CF, Mohareb EW, Yassin AS, Amin MA, El Kholy A, El-Karaksy H, ve ark. Viral etiologies of lower respiratory tract infections among Egyptian children under five years of age. BMC Infect Dis2012;12:350-8.
• 6. Jung HE, He Lee HK. Host Protective Immune Responses against Influenza A Virus Infection. Viruses 2020; 12(5):504.
• 7. Burk M, El-Kersh K, Saad M, Wiemken T, Ramirez J, Cavallazzi R. Viral infection in community-acquired pneumonia: A systematic review and meta-analysis. Eur Respir Rev 2016;25:178-88.
• 8. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20.
• 9. Cavallazzi R, Ramirez JA. Influenza and viral pneumonia. Clin Chest Med 2018;39:703-21.
• 10. Meşe S, Uyanik A, Ozakay A, Ozturk S, Badur S. Influenza surveillance in western Turkey in the era of quadrivalent vaccines: A 2003-2016 retrospective analysis. Hum Vaccin Immunother 2018;14:1899-908.
• 11. Yuki Kondo, Shinichi M, Ryo Yamashita, Takuya Ikeda. Coinfection with SARScov-2 and Influenza A virüs. BMJ Case Rep 2020;13(7): e236812.
• 12. World Health Organization (WHO). Influenza and COVİD-19 - similarities and differences. [cited 17 March 2020]. Available from:https://www.who.int/news-room/q-a-detail/coronavirus-disease- Covid-19-similarities-and-differences-with-Influenza.
• 13. Shuhei Azekawaa, Ho Namkoongb, Keiko Mitamurad, Yoshihiro Kawaokae, Fumitake Saitoa. Co-infection with SARS-cov-2 and Influenza A virüs. Idcases 2020;20:e00775.
• 14. Noh JY, Seong H, Yoon JG, Song JY, Cheong HJ, and Kim WJ. Social distancing against COVİD-19: implication for the control of Influenza . Journal of Korean medical science 2020;35(19).
• 15. T.C. Sağlık Bakanlığı: COVİD-19 Bilgilendirme Platformu. https:// Covid19.saglik.gov.tr/TR-66494/pandemi.html.
• 16. Akova M. COVİD-19 İnfluenza İlişkisi. Türk Tabipler Birliği COVİD- 19 Pandemisi Altıncı Ay Değerlendirme Raporu.
• 17. Centers for Disease Control and Prevention (CDC): Similarities and differences between flu and COVİD-19. Retrieved From: https://www.cdc.gov/flu/symptoms/flu-vs-Covid19.htm
• 18. Gültekingil A. Clinical Features of 2017-2018 Seasonal Influenza Infection: A Single-Center Experience. Cocuk Acil ve Yogun Bakım 2018;5(3):119.
• 19. Çiftçi E, Tuygun N, Özdemir H, Tezer H, Şensoy G, Devrim I, and Doğru Ü. Clinical and epidemiological features of Turkish children with 2009 pandemic Influenza A (H1N1) infection: experience from multiple tertiary paediatric centres in Turkey. Scand J Infect Dis 2011;43:923-9.
• 20. Blanton L, Alabi N, Mustaquim D, Taylor C, Kniss K, Kramer N, et al. Update: Influenza activity in the united states during the 2016–17 season and composition of the 2017–18 Influenza vaccine. MMWR Morb Mortal Wkly Rep 2017;66(25);668-76
• 21. Tran D, Vaudry W, Moore D, Bettinger JA, Halperin SA, Scheifele, et al. Hospitalization for Influenza A Versus B. Pediatrics 2016;138.
• 22. Ahmed F, Zviedrite N, Uzicanin A. Effectiveness of workplace social distancing measures in reducing Influenza transmission: a systematic review. BMC Public Health 2018;18(1):518.
• 23. Cowling BJ, Ali ST, Ng TW, Tsang TK, Li JC, Fong MW, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and Influenza in Hong Kong: an observational study. Lancet Public Health 2020;5(5):e279-88.
• 24. Saunders-Hastings P, Reisman J, Krewski D. Assessing the state of knowledge regarding the effectiveness of interventions to contain pandemic Influenza transmission: a systematic review and narrative synthesis. PLoS One 2016;11:e0168262.